RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 95 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2016. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $558,000 | +40.6% | 62,249 | -15.8% | 0.01% | +60.0% |
| Q2 2016 | $397,000 | +18.2% | 73,962 | +1.4% | 0.01% | 0.0% |
| Q1 2016 | $336,000 | -19.4% | 72,950 | -9.0% | 0.01% | 0.0% |
| Q4 2015 | $417,000 | -1.0% | 80,156 | +15.2% | 0.01% | -16.7% |
| Q3 2015 | $421,000 | -64.2% | 69,592 | -6.5% | 0.01% | -62.5% |
| Q2 2015 | $1,176,000 | +60.0% | 74,462 | +10.2% | 0.02% | +77.8% |
| Q1 2015 | $735,000 | +25.9% | 67,581 | +21.7% | 0.01% | +28.6% |
| Q4 2014 | $584,000 | +6.4% | 55,543 | -2.9% | 0.01% | 0.0% |
| Q3 2014 | $549,000 | -30.7% | 57,206 | -16.5% | 0.01% | -30.0% |
| Q2 2014 | $792,000 | -26.2% | 68,529 | -36.1% | 0.01% | -23.1% |
| Q1 2014 | $1,073,000 | +163.0% | 107,310 | +242.4% | 0.01% | +116.7% |
| Q4 2013 | $408,000 | -53.4% | 31,344 | -46.5% | 0.01% | -71.4% |
| Q3 2013 | $876,000 | +100.9% | 58,639 | +25.7% | 0.02% | +133.3% |
| Q2 2013 | $436,000 | – | 46,649 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|